Yale Jen
Stock Analyst at Laidlaw & Co.
(0.11)
# 4,492
Out of 5,148 analysts
15
Total ratings
6.67%
Success rate
-16.55%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTN Palatin Technologies | Initiates: Buy | $60 | $22.45 | +167.26% | 1 | Dec 12, 2025 | |
| FEMY Femasys | Initiates: Buy | $6.5 | $0.54 | +1,108.18% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiates: Buy | $22 | $4.58 | +380.35% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences | Initiates: Buy | $5 | $0.93 | +437.11% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $39.06 | +168.82% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $9.07 | +109.48% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $120 | $6.78 | +1,669.91% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $113.11 | -57.56% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $475 | $4.27 | +11,024.12% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $225 | $1.70 | +13,135.29% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.54 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.36 | +2,704.26% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.32 | - | 1 | Aug 15, 2023 |
Palatin Technologies
Dec 12, 2025
Initiates: Buy
Price Target: $60
Current: $22.45
Upside: +167.26%
Femasys
Nov 20, 2025
Initiates: Buy
Price Target: $6.5
Current: $0.54
Upside: +1,108.18%
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $4.58
Upside: +380.35%
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $0.93
Upside: +437.11%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $39.06
Upside: +168.82%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $9.07
Upside: +109.48%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $120
Current: $6.78
Upside: +1,669.91%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $113.11
Upside: -57.56%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $475
Current: $4.27
Upside: +11,024.12%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $1.70
Upside: +13,135.29%
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.54
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.36
Upside: +2,704.26%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.32
Upside: -